Hygiena 2012, 57(1):17-21

Alcohol and Breast Cancer - Economic Costs

Iva Šmídová
Masarykova univerzita, Lékařská fakulta, Ústav preventivního lékařství, Brno

Breast cancer is the most common cancer in women. Annually, it affects more than 1 million women worldwide. Thereof, some 11% of the breast cancer incidence can be attributed to alcohol consumption in women. The aim of this article is to create a notion of the proportion of the costs spent to treat breast cancer that can be ascribed to alcohol consumption in the Czech Republic in 2007. The overall amount that is to be spent to treat women patients who regularly consume alcohol is 39 million CZK.

Keywords: alcohol, breast cancer, economics of alcoholism

Received: May 2011; Accepted: October 5, 2011; Published: March 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šmídová I. Alcohol and Breast Cancer - Economic Costs. Hygiena. 2012;57(1):17-21.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2002. Cancer incidence, mortality and prevalence worldwide. IARC Cancer base no. 5. Version 2.0. Lyon: IARC Press; 2004.
    2. Büchler T. Biologická léčba karcinomu prsu. Onkol Péče. 2008;12(2):10-3.
    3. Gold MR, Siegel JE, Russell LB. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
    4. Mamografický screening. Jedna nebo dvě skleničky denně zvyšují u žen riziko rakoviny [Internet]. Brno: Institut biostatistiky a analýz; 2009 [cit. 5. října 2011]. Dostupné z: http://www.mamo.cz/index.php?pg=aktuality&aid=195.
    5. Spelten ER, Verbeek JH, Uitterhoeve AL, Ansink AC, van der Lelie J, de Reijke TM, et al. Cancer, fatigue and the return of patients to work - a prospective cohort study. Eur J Cancer. 2003 Jul;39(11):1562-7. Go to original source... Go to PubMed...
    6. Brown ML, Lipscomb J, Snyder C. The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health. 2001;22:91-113. Go to original source... Go to PubMed...
    7. Široký P, Novák J, Koukalová H. Náklady péče u jednotlivých klinických stadií karcinomu prsu žen. Klin Onkol. 2004;17(1):33-6.
    8. Prevence nemoci a podpora zdraví. Alkohol a jeho vliv na zdraví - pít či nepít? [Internet]. Brno: Lékařská fakulta MU; 2004 [cit. 5. října 2011]. Dostupné z: http://www.cba.muni.cz/prevencenemoci/modules.php?name=Content&pa=showpageπd=8&page=1.
    9. The Milion Women Study: a confidential national study of women's health [Internet]. Oxford: University of Oxford [updated 2010 Jun; cited 2011 Oct 05]. Available from: http://www.millionwomenstudy.org.
    10. Klener P, Abrahámová J, Petruželka L, Žaloudík J, Mališ J, Matějovský Z, et al. Klinická onkologie. Praha: Galén; 2002.
    11. Laino C. Progress in predicting invasive breast cancer. WebMD Health News [Internet]. 2010 April 28 [cited 2011 Oct 05]. Available from: http://www.medicinenet.com/script/main/art.asp?articlekey=115826.
    12. Petráková K. Chemoterapie a hormonální léčba karcinomu prsu. Onkologie. 2009;3(1):12-7.
    13. Wai ES, Trevisan CH, Taylor SCM, Mates D, Jackson JS, Olivotto IA. Health system costs of metastatic breast cancer. Breast Cancer Res Treat. 2001 Feb;65(3):233-40. Go to original source... Go to PubMed...
    14. Du XL, Osborne C, Goodwin JS. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J Clin Oncol. 2002 Dec 15;20(24):4636-42. Go to original source... Go to PubMed...
    15. Phillips KA, Bernhard J. Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. J Natl Cancer Inst. 2003 Feb 5;95(3):190-7. Go to original source... Go to PubMed...
    16. Polder JJ, Meerding WJ, Bonneux L, van der Maas PJ. A cross-national perspective on cost of illness: a comparison of studies from The Netherlands, Australia, Canada, Germany, United Kingdom, and Sweden. Eur J Health Econ. 2005 Sep;6(3):223-32. Go to original source... Go to PubMed...
    17. Karnon J, Kerr GR, Jack W, Papo NL, Cameron DA. Health care costs for the treatment of breast cancer recurrent events: estimates from a UK-based patient-level analysis. Br J Cancer. 2007 Aug 20;97(4):479-85. Go to original source... Go to PubMed...
    18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83. Go to original source... Go to PubMed...
    19. Ozols RF, Herbst RS, Colson YL, Gralow J, Bonner J, Curran WJ Jr, et al.; American Society of Clinical Oncology. Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening - a report from the American Society of Clinical Oncology. J Clin Oncol. 2007 Jan 1;25(1):146-62. Go to original source...
    20. Národní onkologický program. News: bioléčba za miliardy [Internet]. Česká onkologická společnost ČLS JEP; 2008 [cit. 5. října 2011]. Dostupné z: http://www.onconet.eu/index-en.php?s=national-cancer-control-programme&f=news&aid=71.

    Return to the content